David Sinclair startup raises $80M for clinical test of anti-aging gene therapy - Endpoints News
Source:Endpoints.news
Life Biosciences, a startup co-founded by Harvard biologist David Sinclair, has raised an $80 million Series D financing. The money will support a Phase 1 trial of a gene therapy in two forms of vision loss and fund preclinical studies using a similar therapy…
Related Articles
Common bacteria discovered in the eye linked to cognitive decline - Medical Xpress
Chlamydia pneumoniae—a common bacterium that causes pneumonia and sinus infections—can linger in the …
'Zombie' Remnants of COVID-19 Hunt In Packs And Kill Our Immune Cells - ScienceAlert
‘Zombie’ coronavirus fragments not only help drive inflammation in long-COVID, but also …
New guidelines on cholesterol management: Experts explain the updates - AOL.com
The AHA and ACC have recently updated the guidelines for the management of high blood cholesterol. …
COVID vaccination: we now may know why some people developed blood clots - The Conversation
A rare clotting disorder puzzled doctors during the COVID vaccine rollout. New research reveals the …